Research

Abbott, Dexcom could benefit from CGM use jump among Type 2 diabetes patients: report

The population could drive the next wave of demand for devices to track and control diabetes, Jefferies analysts predict, based on polling of roughly 50 endocrinologists and general practitioners.

By Susan Kelly • Oct. 13, 2021

Curating data assets for real-time insights

With the increasing movement toward digitalization, the competitive landscape is beginning to change.

Sept. 27, 2021

Cue, Google's COVID-19 test provider, raises $200M in IPO

The at-home test maker will use the money to scale up commercial and manufacturing infrastructure to support its portable diagnostic platform. Cue Health's Friday debut on the Nasdaq valued the company at $2.9 billion.

By Nick Paul Taylor • Sept. 27, 2021

ResMed touts CPAP survival benefits for sleep apnea after HHS doubts therapy efficacy

The ResMed-funded analysis of a French database comes on the heels of a government review finding the evidence does not back a link between continuous positive airway pressure therapy and clinically important outcomes.

By Greg Slabodkin • Sept. 9, 2021

Hospital telehealth leveling off at one-fifth of medical appointments, research finds

And of the facilities reporting higher virtual volumes, many said they expected telehealth use to decline over the long term, according to the survey from KLAS Research and the Center for Connected Medicine.

By Rebecca Pifer • Sept. 8, 2021

Pandemic spurs rise of other infections contracted at healthcare facilities

The largest increase at hospitals from 2019 to 2020 was seen in bloodstream infections associated with central line catheters, according to the CDC.

By Hailey Mensik • Sept. 2, 2021

Smoking pot before knee, hip replacements linked with more complications

With marijuana use rising quickly in U.S. adults aged 45 to 64 years, three studies presented at the American Academy of Orthopaedic Surgeons meeting sought to find out if consumption affects outcomes.

By Nick Paul Taylor • Sept. 2, 2021

Abbott predicted to quickly take share from Boston Scientific's Watchman: survey

The poll of 56 electrophysiologists by SVB Leerink analysts is somewhat more encouraging for Boston Scientific than an earlier survey, but still highlights the threat to the franchise as it loses its monopoly in the space.

By Nick Paul Taylor • Aug. 26, 2021

Patients were still hesitant to seek medical care out of virus fears this spring, survey finds

Despite reopenings, one in 10 nonelderly adults put off needed medical care this spring, an April survey from the Urban Institute found.

By Hailey Mensik • Aug. 19, 2021

Outpatient revenue drives hospital volume rebound in June, Kaufman Hall says

The report's year-to-date trends in outpatient visit growth add to color from medtech companies reporting electives rebounding in recent financial results.

By Hailey Mensik • Aug. 4, 2021

Mayo Clinic named U.S. News top hospital for sixth straight year

The list, which already examines specialty areas like knee replacements, added seven new measures including care for spinal fusion and hip fracture.

By Shannon Muchmore • July 28, 2021

PerkinElmer inks $5.3B takeover of antibody provider BioLegend

Flush with revenue from COVID-19 testing, the medtech is betting the company can sustain a high growth rate amid competition from BD and Thermo Fisher.

By Nick Paul Taylor • July 27, 2021

Medtech pay to doctors plunged in 2020 as COVID-19 pummeled electives, in-person services fell

Zimmer Biomet had the biggest drop, cutting general payments nearly 80% to $63 million. Other notable decreases include Stryker, J&J's DePuy Synthes and Boston Scientific.

By Ricky Zipp • July 12, 2021

U.S. News hospital rankings to add back surgery, hip fracture and overuse

The publication will rank seven new procedures and conditions, as well as a new category "because a pattern of overuse or low-value care is not compatible with being a high-quality provider."

By Hailey Mensik • June 30, 2021

Black patients were more likely to die of COVID-19 largely due to inferior hospitals

A recent study in JAMA Network Open showed how inequities in housing influence where Black people seek care and how that affects the quality of care they receive.

By Samantha Liss • June 21, 2021

In first, FDA approves KRAS-blocking cancer drug from Amgen

After decades of scientists unsuccessfully targeting the KRAS gene, Lumakras is the first drug proven effective. The FDA Friday also approved companion diagnostics from Qiagen and Guardant Health.

By Ned Pagliarulo • Updated May 29, 2021

Boston Scientific's Watchman shows low stroke rate in large registry at ACC

The fast-growing product performed well in an analysis of more than 36,000 people presented at the American College of Cardiology meeting, with low adverse event rates that surprised even the study's author.

By Susan Kelly • May 17, 2021

Paclitaxel, uncoated stents for PAD show similar mortality in real world study

The review of outcomes for Medicare beneficiaries contrasts a 2018 meta-analysis that identified a mortality signal for patients treated with drug-coated stents and balloons. Still, JAMA editors said mortality rates are troublingly high.

By Susan Kelly • May 17, 2021

TAVR readmission rates vary widely between hospitals for unknown reasons: study

Length of stay and discharge disposition only explained 15% of the inter-hospital variation. The study's authors have called for efforts to identify practices associated with low rates or readmission. 

By Nick Paul Taylor • May 10, 2021

EU MDR delay has not made new rules easier to stomach: exec poll

Most of the 115 respondents to the Climedo Health survey said resources and lack of clarity were top challenges, with about a third indicating compliance efforts will cost their company 5% to 10% of annual revenue.

By Ricky Zipp • April 15, 2021

Fewer heart tests ordered for telehealth patients in pandemic

Research published in JAMA Network Open also found those using the virtual services were more likely to be Asian, Black or Hispanic.

By Susan Kelly • April 6, 2021

Medtechs top pharma in cash to doctors for consulting, travel: Health Affairs study

The majority of sector payments, also covering royalties, speaking fees and food, came from the likes of Medtronic, J&J, Zimmer, Stryker and Abbott. Specialties targeted included neurosurgery, orthopaedics and cardiology. 

By Ricky Zipp • April 6, 2021

Hospitals flailed amid COVID-19 crisis, are unsure of future, OIG says

Executives said they were worried about their workers experiencing trauma and concerned a shrinking recruitment pool for nurses could exacerbate staffing shortages.

By Ron Shinkman • March 25, 2021

AstraZeneca, Oxford vaccine prevents COVID-19 in big US study amid controversy overseas

A two-shot regimen was 79% effective at protecting people from COVID-19, which should support the fourth clearance of a vaccine in the U.S. and calm safety concerns abroad. 

By Ben Fidler • March 22, 2021

Insulin pump adoption seen climbing 21% in 2021 on wearables boom: survey

The SVB Leerink poll of 101 endocrinologists and nurse practitioners also projects a shift in market position among top players like Medtronic, Insulet and Tandem Diabetes Care.

By Ricky Zipp • March 5, 2021